Allianz Asset Management GmbH Grows Position in Globe Life Inc. $GL

Allianz Asset Management GmbH grew its holdings in Globe Life Inc. (NYSE:GL) by 1,259.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 53,007 shares of the company’s stock after purchasing an additional 49,107 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.06% of Globe Life worth $6,588,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of GL. GAMMA Investing LLC raised its holdings in shares of Globe Life by 18.8% in the 1st quarter. GAMMA Investing LLC now owns 5,936 shares of the company’s stock valued at $782,000 after purchasing an additional 941 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Globe Life by 8.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 22,799 shares of the company’s stock valued at $3,003,000 after purchasing an additional 1,861 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in shares of Globe Life by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 9,834 shares of the company’s stock valued at $1,295,000 after purchasing an additional 260 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Globe Life by 42.4% in the 1st quarter. Blue Trust Inc. now owns 772 shares of the company’s stock valued at $102,000 after purchasing an additional 230 shares in the last quarter. Finally, Oppenheimer & Co. Inc. bought a new stake in shares of Globe Life in the 1st quarter valued at about $2,161,000. Institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

GL has been the subject of several recent research reports. Weiss Ratings restated a “buy (b-)” rating on shares of Globe Life in a report on Wednesday, October 8th. Wells Fargo & Company boosted their price objective on shares of Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. BMO Capital Markets reiterated a “market perform” rating and set a $149.00 price objective (up previously from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. JPMorgan Chase & Co. boosted their price objective on shares of Globe Life from $145.00 to $160.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 8th. Finally, Keefe, Bruyette & Woods boosted their price objective on shares of Globe Life from $145.00 to $155.00 and gave the stock an “outperform” rating in a research note on Monday, July 28th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $152.11.

Globe Life Trading Down 0.4%

Shares of Globe Life stock opened at $135.52 on Thursday. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12-month low of $100.27 and a 12-month high of $147.83. The firm has a market capitalization of $10.98 billion, a price-to-earnings ratio of 10.83 and a beta of 0.55. The firm’s 50 day simple moving average is $139.63 and its two-hundred day simple moving average is $129.18.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.52 billion. During the same quarter in the prior year, the business posted $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is presently 8.63%.

Insider Activity at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 28,952 shares of the company’s stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total transaction of $4,081,363.44. Following the transaction, the chief financial officer owned 30,665 shares in the company, valued at approximately $4,322,845.05. This represents a 48.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 33,270 shares of the company’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the transaction, the chief executive officer owned 49,842 shares in the company, valued at $6,758,076.78. The trade was a 40.03% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 84,722 shares of company stock worth $11,733,793. 1.51% of the stock is owned by company insiders.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.